No I am not presuming autologous are better than azer cel. I am asking how significant is the IL-2 to the good results azer cel has acchieved. To me it is clear azer cel has advantages over autologous, cheaper production, and quicker process etc.. But I am concerned that IL-2 is a significant contributer to the results and this can be supplemented to other Car Ts. In so doing it reduces the competitive advantage azer cel demonstrates in this trial, at least in performance.
Ann: Azer-cel demonstrates two additional Complete Responses, page-214
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $89.60M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $140.7K | 11.61M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 9000852 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 6923007 | 25 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |